Phoenix, AZNCT07288489Now EnrollingIRB Ready

Blood Loss, Surgical Clinical Trial in Phoenix, AZ

Access cutting-edge blood loss, surgical treatment through this phase 3 clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.

Sponsored by VarmX B.V.

Quick Self-Assessment

See if you qualify for this Phoenix location

Preparing your pre-screening questions…

Expert Care in Phoenix

Access blood loss, surgical specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related blood loss, surgical treatment provided free

Apply for This Phoenix Location

Check if you qualify for this blood loss, surgical clinical trial in Phoenix, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Phoenix

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Phoenix site if eligible
  4. 4Begin participation

About This Blood Loss, Surgical Study in Phoenix

The goal of this clinical trial is to learn if VMX-C001 works to to allow blood clotting control in participants who take FXa Direct Oral Anticoagulants (DOACs) during surgery or other invasive procedures that carry a high risk of bleeding. The main question it aims to answer is: ● What is the proportion of participants in whom the stopping of bleeding was classed as good or excellent during the procedure, as judged by a group of experts who did not know which treatment was given? Researchers will compare a fixed dose of VMX-C001 to the usual treatment that would be given for the required procedure. Participants will: * Be given either a fixed dose of VMX-C001 or usual treatment before they undergo the required procedure in theatre * Have regular clinical assessments, including laboratory tests, during their hospital stay following the procedure * Return to the clinic for a check-up and tests approximately 28 days after the procedure was conducted.

Sponsor: VarmX B.V.

Who Can Participate

Inclusion Criteria

Male or female patient aged ≥18 years.
The patient or legally authorised representative (LAR) has given written informed consent.
The patient requires urgent surgery/procedure for which the risk of bleeding is considered high and for which haemostasis is considered necessary.
The patient has a significant FXa DOAC level at the time of procedure.
The patient would require treatment (usual pharmacological care) to restore coagulation for the required procedure.
The patient must be willing to use appropriate contraception.

Exclusion Criteria

The patient is known for any reason, other than administration of a FXa DOAC, to have an increased risk of bleeding compared to a patient in a similar clinical situation.
The patient has received any non FXa DOAC anticoagulants within 7 days of Screening or has received heparin (UFH or LMWH) within 3 days of Screening.
The patient has received any of the prespecified medications not allowed in the 7 days prior to Randomisation.
The patient was treated with an investigational drug \<30 days or 5 half-lives, whichever is longer, prior to Screening.
Expected survival, in the Investigator's judgement, is \<3 months due to comorbidity.
Patients in whom the Investigator considers it is not possible to estimate the expected blood loss.
Known "Do Not Resuscitate" order or similar advanced directive.
Cardiogenic shock at the time of screening unless related to the need for the required procedure.
The patient has sepsis (including severe sepsis or septic shock) at the time of screening.
The patient is pregnant or a lactating female.
Known hypersensitivity to any component of VMX-C001 or hamster proteins.
Patients who, in the opinion of the Investigator, should not participate in the study for any other reason, or inability to comply with the protocol.
Prior exposure to VMX-C001.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Phoenix?

Yes, this clinical trial (NCT07288489) has an active research site in Phoenix, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Blood Loss, Surgical Treatment Options in Phoenix, AZ

If you're searching for blood loss, surgical treatment options in Phoenix, AZ, this clinical trial (NCT07288489) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Phoenix research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced blood loss, surgical specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all blood loss, surgical clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Phoenix, AZ

See all interstitial cystitis clinical trials recruiting in Phoenix — not just this study.

Browse Interstitial Cystitis Trials in Phoenix →

Browse More Trials by Condition

Interstitial Cystitis TrialsAll Conditions →

Ready to Join in Phoenix?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Phoenix, AZ